Scholarly Index
Mineo Kurokawa
The University of Tokyo; 18,650 total citations; 658 total publications; best world rank #256
The University of Tokyo
18,650Total citations
658Total publications
68H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Acute Myeloid Leukemia Research | Lifetime | 270 | JP 3 | 99.22 |
| Chronic Myeloid Leukemia Treatments | Lifetime | 447 | JP 7 | 97.96 |
| Cancer-related gene regulation | Lifetime | 788 | JP 86 | 96.47 |
| Hematopoietic Stem Cell Transplantation | Lifetime | 669 | JP 27 | 97.50 |
| Kruppel-like factors research | Lifetime | 256 | JP 23 | 95.07 |
| Protein Degradation and Inhibitors | Lifetime | 707 | JP 17 | 95.36 |
| Myeloproliferative Neoplasms: Diagnosis and Treatment | Lifetime | 656 | JP 11 | 95.59 |
| Histone Deacetylase Inhibitors Research | Lifetime | 847 | JP 22 | 93.40 |
| Hematological disorders and diagnostics | Lifetime | 617 | JP 16 | 92.78 |
| Retinoids in leukemia and cellular processes | Lifetime | 911 | JP 50 | 93.76 |
| Neutropenia and Cancer Infections | Lifetime | 795 | JP 24 | 94.00 |
| TGF-β signaling in diseases | Lifetime | 932 | JP 107 | 89.55 |
| Neutropenia and Cancer Infections | 2021-2025 | 286 | JP 11 | 83.89 |
| Blood disorders and treatments | 2021-2025 | 315 | JP 10 | 78.43 |
| Hematological disorders and diagnostics | 2021-2025 | 357 | JP 9 | 69.82 |
| Histiocytic Disorders and Treatments | 2021-2025 | 876 | JP 49 | 27.81 |